RESEARCHING OF DRUGS USED FOR CORONARY HEART DISEASE REGISTERED IN THE REPUBLIC OF UZBEKISTAN
Keywords:
content analysis, assortment, drugs for coronary heart disease, pharmaceutical market.Abstract
Clinical trials have found that more intensive blood pressure targets reduce PVR compared with standard blood pressure control in middle-aged and older adults. Health policies that create an enabling environment to make healthy lifestyle choices acceptable are essential to motivating people to make and maintain them. Identifying people at highest risk for cardiovascular disease and providing them with appropriate treatment can prevent them from dying prematurely. Access to medicines for noncommunicable diseases and essential health technologies in all primary health care settings is essential to ensure that those in need receive timely treatment and consultation [1].
References
Сердечно-сосудистые заболевания [электронный ресурс] - Режим доступа: https://www.who.int/ru/health-topics/hypertension/cardiovascular-diseases.
Риски сердечно-сосудистых заболеваний в Центральной Азии [электронный ресурс] - Режим доступа: https://review.uz/post/riski-serdechno-sosudistx-zabolevaniy-v-centralnoy-azii.
Государственный Реестр лекарственных препаратов, изделий медицинского назначения и медицинской техники, разрешенных
к применению в медицинской практике Республики Узбекистан 2023 г. (№27)
Шакиров, М. М. Контент-анализ регистрации антигельминтных лекарственных средств в Государственном реестре лекарственных средств и медицинской техники в Республике Узбекистан за 2016–2021
